Gentex [GNTX] vs QuantumScape [QS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gentex wins in 10 metrics, QuantumScape wins in 5 metrics, with 0 ties. Gentex appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGentexQuantumScapeBetter
P/E Ratio (TTM)15.58-16.94QuantumScape
Price-to-Book Ratio2.498.78Gentex
Debt-to-Equity Ratio0.538.72Gentex
PEG Ratio0.960.85QuantumScape
EV/EBITDA10.49-20.91QuantumScape
Profit Margin (TTM)16.82%0.00%Gentex
Operating Margin (TTM)19.05%0.00%Gentex
EBITDA Margin (TTM)19.05%N/AN/A
Return on Equity16.58%-42.00%Gentex
Return on Assets (TTM)10.48%-22.80%Gentex
Free Cash Flow (TTM)$353.54M$-336.69MGentex
Dividend Yield2.13%N/AN/A
1-Year Return-4.90%182.27%QuantumScape
Price-to-Sales Ratio (TTM)2.54N/AN/A
Enterprise Value$5.93B$8.30BQuantumScape
EV/Revenue Ratio2.49N/AN/A
Gross Profit Margin (TTM)34.25%N/AN/A
Revenue per Share (TTM)$11$0Gentex
Earnings per Share (Diluted)$1.77$-0.86Gentex
Beta (Stock Volatility)0.844.86Gentex
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Gentex vs QuantumScape Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gentex-0.94%-4.57%-0.33%19.24%23.35%-1.89%
QuantumScape-1.26%25.75%104.63%126.78%299.00%187.36%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gentex-4.90%13.87%0.40%73.02%167.51%235.93%
QuantumScape182.27%88.85%7.93%62.61%62.61%62.61%

News Based Sentiment: Gentex vs QuantumScape

Gentex

News based Sentiment: MIXED

Gentex delivered strong Q2 results and authorized a stock buyback, attracting institutional investment. However, analyst ratings were mixed, with a downgrade followed by an upgrade, and technical indicators signaled short-term bearish momentum. This creates a complex picture for investors, balancing positive fundamentals with potential near-term volatility.

View Gentex News Sentiment Analysis

QuantumScape

News based Sentiment: MIXED

October presented a mixed bag for QuantumScape, with a significant partnership announcement offset by insider selling and continued analyst caution. The Corning deal is a positive step towards commercialization, but the stock's volatility and mixed signals suggest a complex investment picture. The month's events highlight both the potential and the risks associated with this emerging technology company.

View QuantumScape News Sentiment Analysis

Performance & Financial Health Analysis: Gentex vs QuantumScape

MetricGNTXQS
Market Information
Market Cap i$6.26B$9.26B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,670,73051,898,340
90 Day Avg. Volume i1,916,13738,667,700
Last Close$27.32$15.72
52 Week Range$20.28 - $31.48$3.40 - $16.68
% from 52W High-13.21%-5.76%
All-Time High$37.90 (Nov 15, 2021)$132.73 (Dec 21, 2020)
% from All-Time High-27.92%-88.16%
Growth Metrics
Quarterly Revenue Growth0.15%N/A
Quarterly Earnings Growth0.12%N/A
Financial Health
Profit Margin (TTM) i0.17%0.00%
Operating Margin (TTM) i0.19%0.00%
Return on Equity (TTM) i0.17%-0.42%
Debt to Equity (MRQ) i0.538.72
Cash & Liquidity
Book Value per Share (MRQ)$11.07$1.81
Cash per Share (MRQ)$0.64$1.41
Operating Cash Flow (TTM) i$553.73M$-274,048,000
Levered Free Cash Flow (TTM) i$190.36M$-151,011,744
Dividends
Last 12-Month Dividend Yield i2.13%N/A
Last 12-Month Dividend i$0.60N/A

Valuation & Enterprise Metrics Analysis: Gentex vs QuantumScape

MetricGNTXQS
Price Ratios
P/E Ratio (TTM) i15.58-16.94
Forward P/E i13.13-18.95
PEG Ratio i0.960.85
Price to Sales (TTM) i2.54N/A
Price to Book (MRQ) i2.498.78
Market Capitalization
Market Capitalization i$6.26B$9.26B
Enterprise Value i$5.93B$8.30B
Enterprise Value Metrics
Enterprise to Revenue i2.49N/A
Enterprise to EBITDA i10.49-20.91
Risk & Other Metrics
Beta i0.844.86
Book Value per Share (MRQ) i$11.07$1.81

Financial Statements Comparison: Gentex vs QuantumScape

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GNTXQS
Revenue/Sales i$657.86M$0
Cost of Goods Sold i$432.57MN/A
Gross Profit i$225.29MN/A
Research & Development i$51.47M$101.18M
Operating Income (EBIT) i$125.30M$-123.59M
EBITDA i$163.09M$-92.64M
Pre-Tax Income i$115.47M$-114.70M
Income Tax i$19.82MN/A
Net Income (Profit) i$95.65M$-114.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GNTXQS
Cash & Equivalents i$286.56M$153.56M
Total Current Assets i$1.09B$871.48M
Total Current Liabilities i$266.63M$52.31M
Long-Term Debt iN/A$82.47M
Total Shareholders Equity i$2.48B$1.11B
Retained Earnings i$1.45B$-3.47B
Property, Plant & Equipment iN/A$71.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GNTXQS
Operating Cash Flow i$116.60M$-54.64M
Capital Expenditures i$-36.67M$-5.84M
Free Cash Flow i$111.78M$-66.58M
Debt Repayment iN/A$-784,000
Common Stock Repurchase i$-67.83MN/A

Short Interest & Institutional Ownership Analysis

MetricGNTXQS
Shares Short i7.32M52.46M
Short Ratio i4.022.21
Short % of Float i0.03%0.12%
Average Daily Volume (10 Day) i1,670,73051,898,340
Average Daily Volume (90 Day) i1,916,13738,667,700
Shares Outstanding i227.21M542.55M
Float Shares i218.64M431.52M
% Held by Insiders i0.00%0.19%
% Held by Institutions i1.02%0.33%

Dividend Analysis & Yield Comparison: Gentex vs QuantumScape

MetricGNTXQS
Last 12-Month Dividend i$0.60N/A
Last 12-Month Dividend Yield i2.13%N/A
3-Year Avg Annual Dividend i$0.52N/A
3-Year Avg Dividend Yield i0.43%N/A
3-Year Total Dividends i$1.56N/A
Ex-Dividend DateOct 08, 2025N/A